2008
DOI: 10.1016/j.jsb.2008.07.010
|View full text |Cite
|
Sign up to set email alerts
|

The Arctic mutation alters helix length and type in the 11–28 β-amyloid peptide monomer—CD, NMR and MD studies in an SDS micelle

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
8
0

Year Published

2009
2009
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(10 citation statements)
references
References 77 publications
2
8
0
Order By: Relevance
“…In contrast, the substitution of a charged with a neutral amino acid (E22G) in the central portion of the Arctic peptides might have caused a substantial change in polypeptide conformational features [i.e., a more bent structure as suggested by AFM imaging (see supplemental Fig. 2, available at www.jneurosci.org as supplemental material) (see also Rodziewicz-Motowidło et al, 2008)] associated with a complete loss of neuroprotective activity. This, combined with the rapid aggregation kinetics of the Arctic peptide (Nilsberth et al, 2001;Rodziewicz-Motowidło et al, 2008), might explain the aggressive and early-onset AD associated with this mutation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In contrast, the substitution of a charged with a neutral amino acid (E22G) in the central portion of the Arctic peptides might have caused a substantial change in polypeptide conformational features [i.e., a more bent structure as suggested by AFM imaging (see supplemental Fig. 2, available at www.jneurosci.org as supplemental material) (see also Rodziewicz-Motowidło et al, 2008)] associated with a complete loss of neuroprotective activity. This, combined with the rapid aggregation kinetics of the Arctic peptide (Nilsberth et al, 2001;Rodziewicz-Motowidło et al, 2008), might explain the aggressive and early-onset AD associated with this mutation.…”
Section: Discussionmentioning
confidence: 99%
“…2, available at www.jneurosci.org as supplemental material) (see also Rodziewicz-Motowidło et al, 2008)] associated with a complete loss of neuroprotective activity. This, combined with the rapid aggregation kinetics of the Arctic peptide (Nilsberth et al, 2001;Rodziewicz-Motowidło et al, 2008), might explain the aggressive and early-onset AD associated with this mutation.…”
Section: Discussionmentioning
confidence: 99%
“…The lower sampling of helical conformation (7%) in [G22]Aβ 40 is consistent with the results reported by Rodziewicz-Motowidło et al , which highlighted that E22G mutation lead to shortening of the α-helical fragment. 14 …”
Section: Resultsmentioning
confidence: 99%
“…Out of the above-listed single-point mutations, Arctic-type (E22G) mutation can be examined to obtain key insights into Aβ oligomerization and aggregation processes as Arctic-type Aβ easily form soluble Aβ protofibrils in vitro and has a purely cognitive phenotype typical of AD. 14,15 E22G mutation in Aβ peptide lead to enhanced Aβ aggregation with an increased amount of soluble oligomeric species of Aβ fibrillization. 16,17 A recent study demonstrated the effect of E22G substitution in Aβ 40 2.2.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation